147 related articles for article (PubMed ID: 25081663)
1. Lack of effects of HER-2/neu on prognosis in colorectal cancer: a meta-analysis.
Han J; Meng QY; Liu X; Xi QL; Zhuang QL; Wu GH
Asian Pac J Cancer Prev; 2014; 15(14):5551-6. PubMed ID: 25081663
[TBL] [Abstract][Full Text] [Related]
2. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
3. HER-2 overexpression and survival in colorectal cancer: a meta-analysis.
Li C; Liu DR; Ye LY; Huang LN; Jaiswal S; Li XW; Wang HH; Chen L
J Zhejiang Univ Sci B; 2014 Jun; 15(6):582-9. PubMed ID: 24903996
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies.
Wu SW; Ma CC; Yang Y
Tumour Biol; 2014 Nov; 35(11):10799-804. PubMed ID: 25077923
[TBL] [Abstract][Full Text] [Related]
5. Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.
de Graeff P; Crijns AP; de Jong S; Boezen M; Post WJ; de Vries EG; van der Zee AG; de Bock GH
Br J Cancer; 2009 Jul; 101(1):149-59. PubMed ID: 19513073
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
[TBL] [Abstract][Full Text] [Related]
7. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
8. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis.
Wang Y; Wang D; Ren M
Tumour Biol; 2014 Jan; 35(1):33-8. PubMed ID: 23873100
[TBL] [Abstract][Full Text] [Related]
9. Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis.
Wang S; Zheng G; Chen L; Xiong B
Asian Pac J Cancer Prev; 2011; 12(6):1417-23. PubMed ID: 22229170
[TBL] [Abstract][Full Text] [Related]
10. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
He X; Chen Z; Jia M; Zhao X
PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis.
Wang K; Guan C; Yu J; Jin X; Sun L; Zheng L; Xia L; Zhang Y
Oncotarget; 2017 Sep; 8(43):75528-75543. PubMed ID: 29088888
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.
Chen Z; He X; Xia W; Huang Q; Zhang Z; Ye J; Ni C; Wu P; Wu D; Xu J; Qiu F; Huang J
PLoS One; 2013; 8(12):e80337. PubMed ID: 24324596
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis.
Sun X; Guo S
Pathol Oncol Res; 2020 Jan; 26(1):121-131. PubMed ID: 30519982
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis.
Zhang Y; He S; Yu L; Shi C; Zhang Y; Tang S
BMC Cancer; 2023 Oct; 23(1):1024. PubMed ID: 37875821
[TBL] [Abstract][Full Text] [Related]
16. HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies.
Zhang Q; Liu F; Wang B; Li Z; Zhou D; Yang Q; Dong J; Li J
Medicine (Baltimore); 2016 Jun; 95(23):e3661. PubMed ID: 27281068
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.
Huang CY; Zhou QY; Hu Y; Wen Y; Qiu ZW; Liang MG; Mo JL; Xu JH; Sun C; Liu FB; Chen XL
Oncotarget; 2017 Apr; 8(14):23459-23469. PubMed ID: 28423584
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
Peng L; Zhou Y; Wang Y; Mou H; Zhao Q
PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044
[TBL] [Abstract][Full Text] [Related]
19. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis.
Shi M; Yu B; Gao H; Mu J; Ji C
Mol Biol Rep; 2013 Jan; 40(1):617-23. PubMed ID: 23184003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
